Adherence to omalizumab: a real-life study

被引：0
|
作者：
Campisi, Raffaele [1 ]
Crimi, Claudia [1 ]
Noto, Alberto [2 ]
Foschino, Maria Pia [3 ]
Valenti, Giuseppe [4 ]
Viviano, Vittorio [4 ]
Pelaia, Corrado [5 ]
Ricciardi, Luisa [6 ]
Scichilone, Nicola [7 ]
Crimi, Nunzio [8 ]
机构：
[1] AOU Policlin Vittorio Emanuele, Resp Med Unit, Catania, Italy
[2] AOU Policin G Martino, Anesthesia & Intens Care Unit, Messina, Italy
[3] Univ Foggia, Inst Resp Dis, Dept Med & Surg Sci, Foggia, Italy
[4] Ctr Individuato ASMA GRAVE, Ctr Riferimento Aziendale Terr Prevenz Malattie A, Palermo, Italy
[5] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy
[6] Univ Messina, Sch & Div Allergy & Clin Immunol, Dept Human Pathol, Messina, Italy
[7] Univ Palermo, Sez Pneumol, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy
[8] Univ Catania, Resp Med Unit, Dept Clin & Expt Med, AOU Policlin Vittorio Emanuele, Catania, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; -; management; Quality of life; Adherence;
D O I：
10.1183/13993003.congress-2019.PA2525
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2525
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Does a clinical study reflect real-life and real-life costs
    Juhl, HH
    Hvenegaard, A
    Schmidt, VM
    Habicht, A
    VALUE IN HEALTH, 2005, 8 (03) : 373 - 374
  • [42] Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life experience with omalizumab
    Ediger, Dane
    Günaydin, Fatma Esra
    Erbay, Muee
    Pekbak, Gulseren
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2023, 71 (01): : 24 - 33
  • [43] Treatment adherence: a hurdle for real-life effectiveness in psoriasis?
    Reich, K.
    Dauden, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 : 1 - 3
  • [44] Real-Life Adherence to Venom Immunotherapy and Adrenaline Autoinjector
    Parke, Louise
    Kjaer, Henrik Fomsgaard
    Garvik, Olav Sivertsen
    Halken, Susanne
    Broesby-Olsen, Sigurd
    Bindslev-Jensen, Carsten
    Mortz, Charlotte G.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (03) : 228 - 236
  • [45] Omalizumab in severe asthma: real life study
    Costa e Silva, Margarida
    Sucena, Ines
    Ladeira, Ines
    Franco, Ines
    Pascoal, Ivone
    Carvalho, Aurora
    Lima, Ricardo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [46] Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study
    Rojo-Tolosa, Susana
    Victoria Gonzalez-Gutierrez, Maria
    Antonio Sanchez-Martinez, Jose
    Jimenez-Galvez, Gonzalo
    Elena Pineda-Lancheros, Laura
    Maria Galvez-Navas, Jose
    Jimenez-Morales, Alberto
    Perez-Ramirez, Cristina
    Morales-Garcia, Concepcion
    PHARMACEUTICS, 2023, 15 (02)
  • [47] Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study
    Di Bona, Danilo
    Nettis, Eustachio
    Minenna, Elena
    Lovecchio, Antonella
    Paolino, Donato
    Cristina Nizi, Maria
    Albanesi, Marcello
    Ridolo, Erminia
    Filomena Caiaffa, Maria
    Macchia, Luigi
    ALLERGY, 2020, 75 (10) : 2681 - 2684
  • [48] Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France
    Molimard, Mathieu
    de Blay, Frederic
    Didier, Alain
    Le Gros, Vincent
    RESPIRATORY MEDICINE, 2008, 102 (01) : 71 - 76
  • [49] Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes
    Dursun, A. B.
    Karakis, Pasaoglu G.
    Ayhan, V
    ALLERGY, 2016, 71 : 187 - 187
  • [50] Real-life Efficacy of Omalizumab After 9 Years of Follow-up
    Menzella, Francesco
    Galeone, Carla
    Formisano, Debora
    Castagnetti, Claudia
    Ruggiero, Patrizia
    Simonazzi, Anna
    Zucchi, Luigi
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2017, 9 (04) : 368 - 372
12345